Given the potential clinical application of the consensus molecular classification system for predicting prognosis and response to therapy in CRC patients, the aim of this study was to investigate the potential clinical validity of the CBLL1 gene (Hakai protein) to predict prognosis based on CMS classification. Here, CBLL1 is linked to colorectal carcinoma.